EINDHOVEN, Netherlands, July 9, 2025 – Novenda Technologies has raised $6.1 million in Series A funding to launch its multi-material 3D printing technology. The platform aims to make dental care accessible, affordable, and effective, just as global demand for dental products is reaching new highs.
Addressing a Global Challenge
With nearly 3.5 billion people worldwide struggling with oral diseases – driven by rising sugar consumption and costly dental visits – dental manufacturers face mounting pressure to boost efficiency, especially as centralized production becomes common.
Backing from Leading Investors
The $6.1 million Series A round was led by Brightlands Venture Partners, with participation from KBC Focus Fund (Belgium), Borski Fund (NL), Limburg Business Development Fund/LIOF (NL), angel investors, and an Innovation Credit from RVO.
Olga Goor, Investment Manager at Brightlands Venture Partners, said: “As lead investor, Brightlands Venture Partners is proud to support Novenda Technologies in this next phase of growth. Their multi-material jetting technology is a breakthrough in digital dentistry, enabling scalable, high-precision manufacturing with minimal waste and post-processing. This innovation not only sets a new quality standard for dental products but also enhances affordability of dental care for patients that are unable to afford alternatives currently available in the market. This will ultimately drive the transformation of the dental industry towards a more sustainable and equitable future.”
Nuno Carvalho, Investment Director at KBC Focus Fund, added: “At KBC Focus Fund, we invest in deep-tech companies that push the boundaries of innovation, and Novenda is a prime example of this. Their groundbreaking multi-material jetting technology has the potential to transform the dental industry by enabling cost-effective, high-quality production of dental products with minimal waste and post-processing. We are excited to support Novenda in this next phase of growth as they bring their pioneering solutions to market and redefine digital dentistry.”
A Fresh Approach to Dental Manufacturing
Novenda Technologies was founded in 2019 by Klaas Wiertzema, Petra Doelman, and Joost Anne Veerman. In 2021, their team installed their first printer at the High Tech Campus in Eindhoven and achieved the first multi-material print using their proprietary software.
This full stack technology prints dental products by combining hard materials for protection and soft materials for comfort – all in a single piece. By 2023, they delivered a positive proof of concept for nightguards and dentures.
Traditional methods require manual assembly and post-processing. Novenda’s system uses water-soluble supports that dissolve in tap water and provides print modes for layer deposition without mechanical rollers.
Klaas Wiertzema, CEO and co-founder, explained: “The combination of water-soluble support and the absence of mechanical interventions to compensate for imprecisions ensures unprecedented long-term accuracy and eliminates the need for extensive post-processing. This is particularly important in a world where dental technicians are becoming increasingly scarce and expensive.”
Proven Results and Industry Impact
Novenda’s color management algorithm delivers unlimited color options using a few base colors, while maintaining mechanical properties. Their system outputs up to 15 nightguards or 8 dentures per hour. The LD100 printer uses proprietary, biocompatible materials, ensuring quality and a recurring revenue stream.
Novenda’s launch arrives as the dental market embraces digitization – oral scanners replacing manual impressions, but actual manufacturing lagging behind.
Early industry feedback has been positive, with surface finish and aesthetic appearance of Novenda’s night guards are “the best we have seen,” and suggestions like “multi-material jetting is the future in dental.”
Inventive Culture and Future Plans
Powered by a multidisciplinary team of fifteen across physics, chemistry, materials science, and software engineering, Novenda fosters an atmosphere that encourages innovation. Their technologies are protected by multiple patents, with more underway.
Wiertzema commented: “Having an idea for a disruptive technology is just the beginning. Realizing this vision requires the right people, the right drive, and the right team spirit. At Novenda, we don’t just say that people are our most important asset – we live it. We are deeply committed to fostering a culture that stimulates and supports our team, ensuring that every member is motivated and empowered to achieve the extraordinary. This drive for excellence is reflected in our approach to providing customers with the most reliable and user-friendly printers, combined with the best support they could wish for.”
Novenda is developing its platform for additional dental manufacturing applications and evaluating its use in sectors where individualized mass production is required. As of date, its focus is rolling out to large and mid-sized dental labs in Europe and the US.
Source: Novenda Technologies
About Novenda Technologies
Novenda Technologies, officially registered as Lake3D B.V., was founded in 2019 and is headquartered in Netherlands, with an R&D facility in Eindhoven. The company develops multi-material material-jetting 3D printing systems for dental manufacturing. Its LD100 and LD105 printers are designed to produce custom dental products, such as nightguards and dentures, using up to eight materials in a single build. The printers use an inkjet-based process that deposits micro-droplets of polymer and color material at the voxel level, enabling precise control over mechanical properties and color. Novenda also develops in-house materials and software to ensure compatibility with existing dental lab workflows, minimizing process changes. This approach delivers dental products with strength, aesthetics, and reduced post-processing. The company completed a proof-of-concept in 2023 and secured Series A funding and government support in 2024. It plans a commercial launch in late 2025, targeting dental labs in Europe and the US.